ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 103 filers reported holding ADICET BIO INC in Q3 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $274,275 | -77.7% | 200,201 | -60.4% | 0.09% | -76.1% |
| Q2 2023 | $1,228,773 | -63.2% | 505,668 | -12.8% | 0.38% | -71.4% |
| Q1 2023 | $3,340,800 | -35.6% | 580,000 | 0.0% | 1.35% | -30.6% |
| Q4 2022 | $5,185,200 | -37.1% | 580,000 | 0.0% | 1.94% | -35.1% |
| Q3 2022 | $8,248,000 | -2.6% | 580,000 | 0.0% | 2.99% | -6.9% |
| Q2 2022 | $8,468,000 | -26.9% | 580,000 | 0.0% | 3.21% | -9.5% |
| Q1 2022 | $11,583,000 | – | 580,000 | – | 3.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |